SS
NAMS icon

Sunbelt Securities’s NewAmsterdam Pharma NAMS Stock Holding History

Sunbelt Securities’s Portfolio NAMS Stock Details NAMS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$256 Hold
8
– – ﹤0.01% 2456
2025
Q4 		$281 Hold
8
– – ﹤0.01% 2360
2025
Q3 		$228 Buy
+8
New +$192 ﹤0.01% 2393

Other funds holding NAMS

FLSM
Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
FIS
FCPM III Services Naarden, Netherlands $750M AUM 127.27% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.68B AUM 126.09% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
DFO
Duquesne Family Office New York $5.21B AUM 87.01% 1-Year Est. Return

Sunbelt Securities's NAMS Position: Q1 2026 in Review

Sunbelt Securities held its NewAmsterdam Pharma (NAMS) position steady in Q1 2026 at 8 shares worth $256. The position accounts for ﹤0.01% of the portfolio, ranked #2456.

Sunbelt Securities first reported a position in NAMS in Q3 2025 and has held it in 3 quarters since. The position peaked at $281 in Q4 2025. 171 funds tracked by Wall St. Rank hold NAMS as of Q1 2026.

  • Sunbelt Securities held 8 shares of NewAmsterdam Pharma worth $256 as of Q1 2026.
  • Sunbelt Securities left its NewAmsterdam Pharma share count unchanged in Q1 2026.
  • NewAmsterdam Pharma made up ﹤0.01% of Sunbelt Securities's portfolio in Q1 2026, its #2456 holding.
  • Sunbelt Securities first reported a position in NewAmsterdam Pharma in Q3 2025 and has held it in 3 quarters since.
  • Sunbelt Securities's NewAmsterdam Pharma position peaked at $281 in Q4 2025.
  • 171 funds tracked by Wall St. Rank held NewAmsterdam Pharma as of Q1 2026.

Based on Sunbelt Securities's 13F filing for Q1 2026, filed 18 May 2026.